uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted April 7, 2011

Prostate Drug Found in Prostate Supplement -- Recall Underway

On March 24, 2011 the U.S. FDA posted a voluntary recall notice for U-Prosta from USA Far Ocean Group, Inc. Although marketed as a supplement for "natural" support for prostate health, analysis by the FDA found U-Prosta to contain terazosin, the active ingredient of an FDA-approved drug used to treat Benign Prostatic Hyperplasia (enlarged prostate), making U-Prosta an unapproved drug.

The most likely adverse health consequences that could occur with the use of this product would be hypotension, dizziness, or syncope. Patients who are currently being treated with prescription medications for high blood pressure or enlarged prostate would be at increased risk of these events. In these patients, the hypotensive events may be more severe.

The product has been distributed nationwide via retail stores, internet sales and mail order. All U-Prosta products sold in white plastic bottles (containing 30 or 60 capsules) or as 1-capsule blister packs, are involved in this voluntary recall.

For more information use the link below.